25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
A physician-level review of enclomiphene citrate for secondary hypogonadism in post-bariatric men: pharmacokinetics, absorption concerns, dosing adjustments, monitoring targets, and the evidence base including Kim et al. 2016.
A physician-reviewed analysis of how enclomiphene citrate affects cognitive function, mood, and brain health in men with secondary hypogonadism, including clinical trial data, proposed mechanisms, and dosing context.
A physician-reviewed deep dive into how enclomiphene citrate affects sleep architecture, REM sleep, slow-wave sleep, and testosterone-driven circadian signaling in men with secondary hypogonadism.
Does enclomiphene citrate change appetite or cravings? A clinician-level review of the mechanisms, clinical trial data, and practical guidance for men on enclomiphene therapy.
A clinician-level review of enclomiphene citrate use in patients with autoimmune disease, covering pharmacology, immune-axis interactions, trial data, and practical prescribing guidance for secondary hypogonadism.
A clinician-level review of how enclomiphene citrate affects bone mineral density, estradiol signaling, and fracture risk in men with secondary hypogonadism, with primary-literature citations throughout.
A physician-level review of the cancer risk signals associated with enclomiphene citrate, covering estrogen receptor pharmacology, published trial safety data, and how clinicians should counsel patients on off-label use for secondary hypogonadism.
A clinician-level review of enclomiphene citrate's cardiovascular effects in men with secondary hypogonadism, covering lipid profiles, blood pressure, erythrocytosis risk, and how it compares to exogenous testosterone therapy.
A GRADE-graded review of every major enclomiphene citrate trial, covering testosterone restoration, spermatogenesis, and how the evidence compares to clomiphene and exogenous TRT for secondary hypogonadism.
A physician-reviewed guide to how enclomiphene citrate affects hair growth, hair loss, sebum production, and skin quality in men with secondary hypogonadism, with primary-literature citations throughout.
A physician-reviewed deep dive into how enclomiphene citrate affects liver enzymes, hepatic metabolism, and long-term liver safety, with primary-literature citations throughout.
A clinical deep-dive into how enclomiphene citrate affects mood, cognition, and mental health in men with secondary hypogonadism, with primary-literature citations and practical prescribing guidance.
A physician-reviewed deep dive into enclomiphene citrate microdosing protocols for secondary hypogonadism, covering clinical trial data, dose-titration strategies, monitoring parameters, and how microdosing compares to standard dosing.
How enclomiphene citrate restores endogenous testosterone to support muscle preservation in secondary hypogonadism. Evidence-based dosing, monitoring, and adjunct strategies reviewed by the HealthRX medical team.
MD/PharmD-level guide to diagnosing and fixing enclomiphene citrate plateaus and non-response: dose adjustments, lab interpretation, SHBG correction, thyroid co-factors, and when to switch therapy.
When and how long to hold enclomiphene citrate before surgery, with evidence-based dosing, pharmacokinetics, and perioperative management protocols for clinicians and patients.
A physician-reviewed deep dive into what happens to testosterone, LH, FSH, and spermatogenesis after stopping enclomiphene citrate, including timeline data, risk factors, and clinical restart protocols.
A clinician-level review of how season, circadian rhythm, and environmental light exposure affect enclomiphene citrate dosing strategy, testosterone targets, and monitoring intervals for men with secondary hypogonadism.
A physician-reviewed guide to how enclomiphene citrate affects libido, erectile function, and sperm production in men with secondary hypogonadism, with primary-literature citations and dosing context.
MD/PharmD-level guide to maintaining enclomiphene citrate dosing schedules across time zones, managing missed doses during travel, and monitoring testosterone while abroad.
A physician-level comparison of compounded enclomiphene citrate versus branded formulations for secondary hypogonadism, covering pharmacology, regulatory status, clinical trial data, dosing, and how to choose the right option.
A physician-reviewed deep dive into how enclomiphene citrate affects testosterone, metabolic rate, body composition, and energy expenditure, with primary-literature citations and clinical dosing guidance.
A physician-reviewed, primary-literature analysis of enclomiphene citrate's effects on kidney function in men treated for secondary hypogonadism, including mechanism, clinical trial data, and prescribing guidance.
A physician-level guide to safely restarting enclomiphene citrate after acute illness, covering when to pause, how to re-titrate, and what lab values guide the decision.
A clinician-reviewed, week-by-week guide to enclomiphene citrate for secondary hypogonadism: expected testosterone changes, symptom timelines, lab targets, and dose-adjustment checkpoints for the first 30 days.